Numerai’s LeMaitre Vascular LMAT Stock Holding History

Numerai’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$850K	Buy	7,786 +725	+10%	+$69.1K	0.09%	382
2025 Q4	$573K	Buy	+7,061	New	+$608K	0.07%	372

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Numerai's LMAT Position: Q1 2026 in Review

Numerai increased its LeMaitre Vascular (LMAT) stake by 10% in Q1 2026, buying an estimated $69.1K and bringing the position to 7,786 shares worth $850K. The position accounts for 0.09% of the portfolio, ranked #382.

Numerai first reported a position in LMAT in Q4 2025 and has held it in 2 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

Numerai held 7,786 shares of LeMaitre Vascular worth $850K as of Q1 2026.
Numerai bought 725 LeMaitre Vascular shares in Q1 2026, an estimated $69.1K.
LeMaitre Vascular made up 0.09% of Numerai's portfolio in Q1 2026, its #382 holding.
Numerai first reported a position in LeMaitre Vascular in Q4 2025 and has held it in 2 quarters since.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Numerai's 13F filing for Q1 2026, filed 15 May 2026.